fullerene c60 has been researched along with Neurodegenerative Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lin, CM; Lu, TY | 1 |
| Grebowski, J; Kazmierska, P; Krokosz, A | 1 |
| Gilmore, JL; Kabanov, AV; Quan, L; Yi, X | 1 |
2 review(s) available for fullerene c60 and Neurodegenerative Diseases
| Article | Year |
|---|---|
Fullerenols as a new therapeutic approach in nanomedicine.
Topics: Anthracyclines; Drug Carriers; Fullerenes; Humans; Nanomedicine; Neoplasms; Neurodegenerative Diseases; Oxidative Stress; Water | 2013 |
Novel nanomaterials for clinical neuroscience.
Topics: Animals; Biopolymers; Blood-Brain Barrier; Central Nervous System Diseases; Coated Materials, Biocompatible; Drug Delivery Systems; Drug Evaluation, Preclinical; Fullerenes; Humans; Hydrophobic and Hydrophilic Interactions; Materials Testing; Nanogels; Nanostructures; Nanotubes, Carbon; Nerve Regeneration; Neurodegenerative Diseases; Neuroprotective Agents; Oxidative Stress; Pharmaceutical Vehicles; Polyethylene Glycols; Polyethyleneimine; Tissue Scaffolds | 2008 |
1 other study(ies) available for fullerene c60 and Neurodegenerative Diseases
| Article | Year |
|---|---|
C60 fullerene derivatized nanoparticles and their application to therapeutics.
Topics: Antiviral Agents; Blood-Brain Barrier; Drug Carriers; Fullerenes; HIV Infections; Humans; Nanomedicine; Nanoparticles; Nanotechnology; Neurodegenerative Diseases; Pharmaceutical Preparations; Photochemotherapy | 2012 |